Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-11-000131
Filing Date
2011-01-07
Accepted
2011-01-07 15:27:36
Documents
11
Period of Report
2010-11-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT immucor_10q-113010.htm 10-Q 1303520
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 13871
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 13942
4 EXHIBIT 32.1 ex32-1.htm EX-32.1 5426
5 EXHIBIT 32.2 ex32-2.htm EX-32.2 5428
  Complete submission text file 0001437749-11-000131.txt   4825670

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT blud-20101130.xml EX-101.INS 929099
7 XBRL TAXONOMY EXTENSION SCHEMA blud-20101130.xsd EX-101.SCH 17492
8 XBRL TAXONOMY EXTENSION CALCULATION blud-20101130_cal.xml EX-101.CAL 27988
9 XBRL TAXONOMY EXTENSION DEFINITION blud-20101130_def.xml EX-101.DEF 16906
10 XBRL TAXONOMY EXTENSION LABEL blud-20101130_lab.xml EX-101.LAB 106636
11 XBRL TAXONOMY EXTENSION PRESENTATION blud-20101130_pre.xml EX-101.PRE 74122
Mailing Address 3130 GATEWAY DR P O BOX 5625 NORCROSS GA 30091-5625
Business Address 3130 GATWAY PO BOX 5625 NORCROSS GA 30091 770 441 2051
IMMUCOR INC (Filer) CIK: 0000736822 (see all company filings)

EIN.: 222408354 | State of Incorp.: GA | Fiscal Year End: 0531
Type: 10-Q | Act: 34 | File No.: 000-14820 | Film No.: 11517410
SIC: 2835 In Vitro & In Vivo Diagnostic Substances